Evaxion Biotech A/S Files March 2025 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Mar 27, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion Biotech A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Evaxion Biotech A/S filed its monthly 6-K report on 3/27/25, standard procedure for foreign issuers.
AI Summary
Evaxion Biotech A/S filed a Form 6-K on March 27, 2025, to report for the month of March 2025. The company is a foreign private issuer based in Hoersholm, Denmark, and is incorporated in G7. Evaxion Biotech A/S is listed under the SIC code 2836 for Biological Products.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Evaxion Biotech A/S's ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine monthly report for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.
Key Numbers
- 001-39950 — Commission File Number (Identifies the company's filing with the SEC.)
- 2836 — SIC Code (Classifies Evaxion Biotech A/S in the Biological Products industry.)
Key Players & Entities
- Evaxion Biotech A/S (company) — Registrant
- 001-39950 (company) — Commission File Number
- 2836 (company) — Standard Industrial Classification Code
- Dr. Neergaards Vej 5f (company) — Business and Mail Address
- Hoersholm, Denmark (company) — Location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What period does this Form 6-K cover?
This Form 6-K is for the month of March 2025.
Where is Evaxion Biotech A/S headquartered?
Evaxion Biotech A/S is headquartered in Hoersholm, Denmark.
What is Evaxion Biotech A/S's Standard Industrial Classification (SIC) code?
Evaxion Biotech A/S's SIC code is 2836, which corresponds to Biological Products (no diagnostic substances).
Does Evaxion Biotech A/S file annual reports under Form 20-F?
Yes, Evaxion Biotech A/S indicates with a checkmark that it files or will file annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 27, 2025 regarding Evaxion Biotech A/S (EVAX).